Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Gastric Cancer 2019-01-17 08:00
Applied Spectral Imaging (ASI) reveals advanced FISH solutions that deliver ultra-fast imaging analysis 2019-01-17 00:01
Neurotech Pharmaceuticals, Inc. and Lowy Medical Research Institute Announce Publication of NT-501 Phase 2 Results 2019-01-16 22:34
Bridge Biotherapeutics Announces FDA Orphan Drug Designation for BBT-877 in Idiopathic Pulmonary Fibrosis (IPF) 2019-01-16 22:00
Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases 2019-01-14 08:30
MGI Announces Price and Early Access Customer of MGISEQ-T7 2019-01-10 05:51
Plantar Stimulation Therapy Offers Simple, Non-Invasive Treatment for Painful Conditions Such as Fibromyalgia 2019-01-07 23:45
Stemedica Cell Technologies Reports Positive Data in Phase I/IIa Study of Allogeneic Stem Cells for Ischemic Stroke 2019-01-07 22:09
China Biologic Reiterates Full Year 2018 Financial Forecast 2019-01-07 21:00
Alphamab Oncology is Invited to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-04 17:02
Gathering Quality Pharmaceutical Excipients from Around the World, PharmaExcipients China 2019 Helps the Chinese Pharmaceutical Industry Achieve Comprehensive Upgrading 2019-01-04 15:00
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology 2019-01-04 09:30
Dr. Jan M. Lundberg, Former Head of R&D at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors 2019-01-03 17:49
ProBioGen's GlymaxX(R) ADCC Enhancement Technology Used by Betta Pharmaceuticals 2019-01-03 17:22
Sinovant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-03 09:00
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company 2019-01-02 12:37
APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene 2019-01-02 08:00
Ascletis' Ganovo Enrolled in the Basic Medical Insurance of Chengdu 2019-01-02 08:00
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Esophageal Cancer 2019-01-02 08:00
MEDI FUTURES Raises US$5M Funding Led by Samho Green Investment 2018-12-28 21:00
1 322 323 324 325 326 450